CMS and Joint Commission Pain Assessment Documentation
- CMS Conditions of Participation for hospitals under 42 CFR 482.13(e) require that each patient have the right to appropriate assessment and management of pain, and that hospitals ensure clinical staff have the competency to assess and treat pain safely. Hospital discharge planning requirements under 42 CFR 482.43 require that discharge instructions address ongoing medication management, which includes post-operative analgesic prescriptions. CMS surveyors assess pain management documentation as part of the patient rights and discharge planning standards, reviewing clinical records for evidence of systematic pain assessment and documented patient education on prescribed analgesics.
- Joint Commission pain management standards for accredited hospitals and ambulatory surgical centers, documented in CAMH Standard PC.01.02.07 and related standards, require organizations to screen patients for pain and, when screening indicates a need, perform a more comprehensive assessment. The Joint Commission requires that pain assessment results be documented in a way that facilitates regular reassessment and follow-up. For surgical patients, post-operative pain assessment must be performed at regular intervals, and the clinical record must reflect the pain level, the intervention provided, and the patient's response. These documentation requirements apply through the post-anesthesia recovery and discharge phases.
- Discharge pain assessment documentation should record the patient's reported pain level using a validated, age-appropriate pain scale at the time of discharge: the Numeric Rating Scale for adults and the FACES scale for pediatric patients who cannot use a numeric scale. The clinical record must also document the analgesic regimen prescribed, the patient's demonstrated understanding of the regimen, and the criteria for contacting the provider if pain is not adequately controlled. For patients whose discharge pain level exceeds the facility's defined discharge threshold, typically a numeric score above 4 to 5 on a 10-point scale with activity, the clinical record must document the treating clinician's rationale for discharge including an assessment that the pain level is appropriate given the patient's functional status and planned analgesic regimen.
- ERAS (Enhanced Recovery After Surgery) protocol documentation for surgical practices that have implemented multimodal analgesic pathways includes recording pre-operative analgesic premedication (acetaminophen, gabapentinoids, or NSAIDs where indicated by the ERAS pathway), intraoperative analgesic techniques (regional nerve blocks, wound infiltration, or intravenous adjuncts), and the post-operative multimodal regimen prescribed at discharge. Per systematic reviews published by the American Society of Anesthesiologists, multimodal analgesia with scheduled acetaminophen and NSAIDs as a foundation for post-operative pain management reduces total opioid consumption and opioid-related adverse effects across a range of surgical procedures. Documentation of ERAS protocol adherence supports quality reporting and provides a contemporaneous record for malpractice defense.
Opioid Prescribing Documentation and DEA Compliance at Discharge
- DEA prescribing requirements for controlled substances under 21 CFR Part 1306 require that each prescription for a Schedule II through Schedule V controlled substance include the patient's full name and address, the date of issue, the drug name, strength, and quantity prescribed, directions for use, and the prescribing practitioner's DEA registration number and signature. Prescriptions for Schedule II controlled substances, including oxycodone, hydromorphone, and oxymorphone, may not be refilled and require a new manually signed prescription for each dispensing. Emergency oral prescription authorization for Schedule II drugs is available under 21 CFR 1306.11(d) in limited circumstances, but the prescriber must provide a signed written prescription to the pharmacy within 7 days.
- State PDMP compliance at the time of opioid prescribing is required in the majority of states for prescriptions of Schedule II and Schedule III opioids. As of 2025, 49 states and the District of Columbia operate PDMPs, and most require prescribers to query the PDMP before prescribing opioids for new patients or at defined intervals for existing patients, per state-specific regulations. Surgical practice administrators should confirm the query requirements, exemptions, and documentation standards applicable in their state. PDMP query documentation should be maintained in the patient's clinical record, with notation of the query date, the database queried, and the prescribing decision made in light of the PDMP findings.
- Opioid quantity limits at discharge are established by state prescribing statutes in a growing number of states, with many setting a maximum initial opioid supply for acute pain conditions, commonly 3 to 7 days for initial prescriptions. Surgical practices must document the clinical rationale for opioid quantities prescribed at discharge, particularly where quantities approach or require a documented exception to an applicable state limit, as most states provide surgical exceptions based on documented clinical need. The discharge record should include the opioid prescribed, the quantity dispensed, the estimated analgesic duration, and the criteria under which a refill or transition to non-opioid analgesia will be considered.
- Patient education documentation for opioid prescriptions at discharge must address safe use, storage, and disposal requirements. CMS and the Joint Commission both assess whether clinical staff provide patients with education on the risks of opioid use, including sedation, respiratory depression, constipation, and the potential for misuse. Discharge instructions for patients receiving opioids should specify the prescribed regimen, the warning signs of opioid-related adverse effects requiring provider contact (unresponsiveness, slow or shallow breathing, severe constipation), instructions for secure storage away from children and non-prescribed users, and a disposal plan for unused opioids consistent with FDA disposal guidelines, at an authorized drug take-back program or using an FDA-approved in-home disposal product.
Multimodal Analgesia and NSAID and Acetaminophen Documentation Requirements
- Patients discharged with a continuous peripheral nerve block catheter require specific documentation addressing catheter insertion site care and dressing management, the signs of catheter displacement or site infection, the expected duration of continuous infusion, the process for catheter removal after the infusion is complete, and the symptoms of local anesthetic toxicity: circumoral numbness, tinnitus, metallic taste, or cardiac symptoms requiring emergency evaluation. The clinical record should document the nerve block performed, the local anesthetic and concentration used, and the volume infused during the procedure. Patients and caregivers must receive written instructions covering each of these elements before leaving the facility.
- NSAID prescribing documentation for post-operative multimodal analgesia should address contraindications assessed before prescribing, including renal impairment (NSAIDs are contraindicated when the estimated GFR falls below 30 mL/min per 1.73 m2), cardiovascular risk (selective COX-2 inhibitors and non-selective NSAIDs carry an FDA class warning for cardiovascular events), active or recent peptic ulcer disease or gastrointestinal bleeding, and perioperative renal dysfunction. Where NSAIDs are withheld because of identified contraindications, the discharge documentation should reflect this decision and specify the alternative analgesic approach selected. For patients who receive NSAIDs, documentation should specify the drug, dose, frequency, and maximum duration of use.
- Acetaminophen dosing documentation at discharge requires attention to cumulative daily dose limits. Per CDC data, acetaminophen-related hepatotoxicity is the leading cause of acute liver failure in the United States. The FDA-recommended maximum daily dose is 4,000 mg for healthy adults, with a practical target of 3,000 mg or less per day for older adults, patients with chronic alcohol use, and patients with underlying hepatic disease. Discharge instructions should specify the acetaminophen dose and frequency prescribed, the maximum daily dose limit, and the instruction to avoid concurrent use of other acetaminophen-containing products, including combination opioid-acetaminophen formulations, to prevent inadvertent dose stacking.
- Follow-up documentation for patients prescribed opioids at discharge should include a scheduled post-operative visit within 2 to 4 weeks for major procedures, with the plan for opioid taper assessment and transition to non-opioid analgesia documented in the discharge record. Practices that use PDMP data to assess opioid utilization at the post-operative visit should document the query results and any prescribing decisions made in response. The discharge record should specify whether refills of the opioid prescription are anticipated and the criteria under which refills will be considered, as failure to communicate a refill policy at discharge contributes to patient uncertainty and unplanned provider contacts in the post-operative period.